Cargando…

The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group

Tuberculosis (TB) is still responsible for the deaths of >1 million people yearly worldwide, and therefore its correct diagnosis is one of the key components of any TB eradication programme. However, current TB diagnostic tests have many limitations, and improved diagnostic accuracy is urgently n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melkie, Solomon Tibebu, Arias, Lilibeth, Farroni, Chiara, Jankovic Makek, Mateja, Goletti, Delia, Vilaplana, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489037/ https://www.ncbi.nlm.nih.gov/pubmed/35264411 http://dx.doi.org/10.1183/16000617.0218-2021

Ejemplares similares

Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)
por: Ong, Catherine Wei Min, et al.
Publicado: (2020)

Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries?
por: Méchaï, Frédéric, et al.
Publicado: (2020)

Cording Mycobacterium tuberculosis Bacilli Have a Key Role in the Progression towards Active Tuberculosis, Which is Stopped by Previous Immune Response
por: Arias, Lilibeth, et al.
Publicado: (2020)

Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
por: Vita, Serena, et al.
Publicado: (2022)

Nintedanib treatment for bleomycin-induced lung injury - First report
por: Rnjak, Dina, et al.
Publicado: (2023)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Tuberculosis Biomarkers: From Diagnosis to Protection
por: Goletti, Delia, et al.
Publicado: (2016)

Drosophila melanogaster as a model to study innate immune memory
por: Arch, Marta, et al.
Publicado: (2022)

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
por: Guglielmetti, Lorenzo, et al.
Publicado: (2022)

Influence of Gut Microbiota on Progression to Tuberculosis Generated by High Fat Diet-Induced Obesity in C3HeB/FeJ Mice
por: Arias, Lilibeth, et al.
Publicado: (2019)

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
por: Esmail, Hanif, et al.
Publicado: (2020)

Cytometric detection of antigen-specific IFN-γ/IL-2 secreting cells in the diagnosis of tuberculosis
por: Sargentini, Valeria, et al.
Publicado: (2009)

Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
por: Goletti, Delia, et al.
Publicado: (2007)

Editorial: Tuberculosis and Non-tuberculous Mycobacteria Infections: Control, Diagnosis and Treatment
por: Opota, Onya, et al.
Publicado: (2021)

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
por: Aiello, Alessandra, et al.
Publicado: (2023)

Risk factors and severity of functional impairment in long COVID: a single-center experience in Croatia
por: Banić, Marko, et al.
Publicado: (2022)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

New synthetic lipid antigens for rapid serological diagnosis of tuberculosis
por: Jones, Alison, et al.
Publicado: (2017)

Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children
por: Sali, Michela, et al.
Publicado: (2015)

Tuberculosis and Its Prophylaxis
por: Halbert, O. I.
Publicado: (1906)

Protective Effect of Intestinal Helminthiasis Against Tuberculosis Progression Is Abrogated by Intermittent Food Deprivation
por: Garrido-Amaro, Cristina, et al.
Publicado: (2021)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
por: Agrati, Chiara, et al.
Publicado: (2022)

Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
por: Goletti, Delia, et al.
Publicado: (2008)

Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic
por: Farrés, Judith, et al.
Publicado: (2021)

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
por: Petruccioli, Elisa, et al.
Publicado: (2016)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)

A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis
por: Leung-Theung-Long, Stéphane, et al.
Publicado: (2018)

Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell
por: Soldevilla, Pablo, et al.
Publicado: (2022)

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
por: Grifoni, Alba, et al.
Publicado: (2023)

Medical Society of Berlin: Prophylaxis of Tuberculosis
Publicado: (1889)

Detection of Pulmonary tuberculosis: comparing MR imaging with HRCT
por: Busi Rizzi, Elisa, et al.
Publicado: (2011)

Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
por: Goletti, Delia, et al.
Publicado: (2021)

Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children
por: Petrone, Linda, et al.
Publicado: (2015)

The use of antibodies in the prophylaxis and treatment of infections
por: Lachmann, Peter J
Publicado: (2012)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis
por: Parlato, Stefania, et al.
Publicado: (2018)

Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis
por: Xia, Hui, et al.
Publicado: (2015)

The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies
por: Vilaplana, Cristina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6uma5roc98aqppv24r7bqdbenm